CCK
Crown Holdings, Inc.
CCK's fundamentals are mixed: revenue grew 13%, but earnings per share fell 11%. At 17x earnings, it's trading below its usual 21x. Analysts expect earnings growth.
CCK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
CCK's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
CCK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $120 | — |
| Cheap | 16x | $118 | -2.4% |
| Current | 17x | $120 | — |
| Fair | 21x | $149 | +24% |
| Expensive | 25x | $178 | +48% |
Historical ranges are pointers, not guarantees.
CCK's PE is in its cheap range at 17x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
CCK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CCK, with profitability holding steady.
CCK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.74 | +22% |
| Q3 2026 | $7.19 | -11% |
| Q2 2026 | $6.96 | +47% |
| Q1 2026 | $6.29 | +36% |
| Q4 2025 | $6.38 | +80% |
| Q3 2025 | $8.07 | +896% |
| Q2 2025 | $4.75 | +32% |
| Q1 2025 | $4.64 | +34% |
| Q4 2024 | $3.55 | -5.6% |
CCK earned $7.19 per share over the past year, down 11% from the year before.
CCK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +16% |
| Q2 2026 | $3.7B | +16% |
| Q1 2026 | $3.3B | +13% |
| Q4 2025 | $3.1B | +7.7% |
| Q3 2025 | $3.2B | +4.2% |
| Q2 2025 | $3.1B | +3.6% |
| Q1 2025 | $2.9B | +3.7% |
| Q4 2024 | $2.9B | +1.6% |
CCK's revenue has grown year over year for nine quarters in a row: $3.7B last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -1.3 points |
| Q2 2026 | 13% | +0.2 points |
| Q1 2026 | 11% | -1.4 points |
| Q4 2025 | 12% | -0.1 points |
| Q3 2025 | 13% | -1.2 points |
| Q2 2025 | 12% | -0.1 points |
| Q1 2025 | 13% | +3.8 points |
| Q4 2024 | 12% | +3 points |
CCK's operating margin was 12% last quarter, down 1.3 points from the same quarter a year ago.
CCK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $299M | -39% |
| Q2 2026 | $597M | +52% |
| Q1 2026 | -$141M | -$122M |
| Q4 2025 | $255M | +75% |
| Q3 2025 | $488M | +2.1% |
| Q2 2025 | $393M | +8.9% |
| Q1 2025 | -$19M | +$177M |
| Q4 2024 | $146M | -67% |
CCK generated $1B in free cash flow over the past year, about the same as the year before.
CCK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -1.5M shares |
| 1 year | -6.4% | -7.4M shares |
| 3 years | -9.5% | -11.4M shares |
| 5 years | -16% | -21.4M shares |
| Available history | -20% | -26.9M shares |
CCK has 108M diluted shares, down 6.4% from a year ago, with $789M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $81M |
| Q2 2026 | $305M |
| Q1 2026 | $212M |
| Q4 2025 | $191M |
| Q3 2025 | $105M |
| Q2 2025 | $6M |
| Q1 2025 | $203M |
| Q4 2024 | $100M |
CCK spent $789M buying back its own shares over the past year, up 91% from the year before.
CCK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.5x | Moderate |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 2.6x | Moderate |
CCK's net debt is about 2.5 years of its operating earnings (EBITDA).
CCK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.6 | Neutral |
| Stochastic | 77.9 | Neutral |
CCK's weekly RSI is 63 (neutral) and its Stochastic is 78 (neutral).
CCK PE vs Consumer Cyclical Sector
| Metric | CCK | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7% below |
| PE % | 19 | 47 | 28 pts below |
CCK is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
CCK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $114.4 | 5.4% above |
| 20 week MA | $115.4 | 4.4% above |
| 50 week MA | $108.1 | 11% above |
| 100 week MA | $101.1 | 19% above |
| 200 week MA | $93.1 | 29% above |
CCK is in an uptrend: it's above all five of its weekly moving averages, and 29% above its 200-week average.
CCK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $73.2 | $98.6 | +35% |
| 2021 | $98.6 | $105.7 | +7.2% |
| 2022 | $105.7 | $82.6 | -22% |
| 2023 | $82.6 | $92.1 | +12% |
| 2024 | $92.1 | $83.2 | -9.7% |
| 2025 | $83.2 | $102.9 | +24% |
| 2026 YTD | $102.9 | $120.5 | +17% |
CCK has finished higher in four of the last six years. It's up 17% so far in 2026.